Skip to main content
Top
Published in: Archives of Public Health 1/2015

Open Access 01-12-2015 | Poster presentation

Phase III randomised chemoprevention study of Selenium on the recurrence of non-invasive bladder cancer. The SELEnium and BLAdder cancer Trial (SELEBLAT)

Authors: Maria (Mieke) Goossens, Maurice Zeegers, Hendrik Van Poppel, Steven Joniau, Koen Ackaert, Filip Ameye, Ignace Billiet, Kurt Dillen, Lieven Goeman, Siska Van Bruwaene, Frank Van der Aa, Kris Vekemans, Frank Buntinx

Published in: Archives of Public Health | Special Issue 1/2015

Login to get access

Excerpt

In Belgium, bladder cancer is the fifth most common cancer in males (5.2%) and the sixth most frequent cause of death from cancer in males (3.8 %). The per-patient lifetime cost is the highest of all other types of cancer. Previous epidemiological studies have consistently reported that selenium concentrations were inversely associated with the risk of bladder cancer. We therefore hypothesized that selenium may also be suitable for chemoprevention of recurrence. …
Metadata
Title
Phase III randomised chemoprevention study of Selenium on the recurrence of non-invasive bladder cancer. The SELEnium and BLAdder cancer Trial (SELEBLAT)
Authors
Maria (Mieke) Goossens
Maurice Zeegers
Hendrik Van Poppel
Steven Joniau
Koen Ackaert
Filip Ameye
Ignace Billiet
Kurt Dillen
Lieven Goeman
Siska Van Bruwaene
Frank Van der Aa
Kris Vekemans
Frank Buntinx
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Archives of Public Health / Issue Special Issue 1/2015
Electronic ISSN: 2049-3258
DOI
https://doi.org/10.1186/2049-3258-73-S1-P5

Other articles of this Special Issue 1/2015

Archives of Public Health 1/2015 Go to the issue